NxStage Medical Inc (NASDAQ:NXTM)

26.45
Delayed Data
As of May 18
 +0.25 / +0.95%
Today’s Change
21.02
Today|||52-Week Range
29.93
+9.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues301.5M336.1M366.4M393.9M
 
 
 
 
 
Cost of Goods Sold157.6M171.7M178.9M191.7M
 
 
 
 
 
Depreciation And Amortization27.7M30.7M32.6M34.4M
 
 
 
 
 
 
Operating ExpensesGross Income116.2M133.7M154.9M167.9M
 
 
 
 
 
General Expenses138.1M146.1M156.3M176.2M
 
 
 
 
 
Other Operating Expenses0.00526.0K457.0K445.0K
 
 
 
 
Research And Development22.6M26.2M31.0M39.6M
 
 
 
 
 
Total Operating Expenses323.4M349.0M368.3M402.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.9M-12.9M-1.9M-8.8M
 
 
 
 
 
Extraordinary Charge-----500.0K-6.2M
 
 
 
Interest Expense On Debt863.0K1.1M1.0M756.0K
 
 
 
 
 
Other Expenses-268.0K-1.2M-2.8M300.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.1M-15.2M-6.2M-15.5M
 
 
 
 
 
Income Taxes-1.3M-1.1M-1.1M-145.0K
 
 
 
 
 
Minority Interest-367.0K-918.0K-2.5M-852.0K
 
 
 
 
 
Net Income-23.9M-15.3M-4.8M-14.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.7M63.4M64.5M65.9M
 
 
 
 
 
Shares To Calculate EPS Diluted61.7M63.4M64.5M65.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.24-$0.07-$0.22
 
 
 
 
 
EPS Diluted-$0.39-$0.24-$0.07-$0.22